ANTIOBESITY DRUGS
\ˌantɪə͡ʊbˈiːsətˌi dɹˈʌɡz], \ˌantɪəʊbˈiːsətˌi dɹˈʌɡz], \ˌa_n_t_ɪ__əʊ_b_ˈiː_s_ə_t_ˌi d_ɹ_ˈʌ_ɡ_z]\
Sort: Oldest first
-
Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.